These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 9888133)

  • 41. Sustained release of intravitreal flurbiprofen from a novel drug-in-liposome-in-hydrogel formulation.
    Pachis K; Blazaki S; Tzatzarakis M; Klepetsanis P; Naoumidi E; Tsilimbaris M; Antimisiaris SG
    Eur J Pharm Sci; 2017 Nov; 109():324-333. PubMed ID: 28843864
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intravitreal penetration of oral ciprofloxacin in humans.
    el Baba FZ; Trousdale MD; Gauderman WJ; Wagner DG; Liggett PE
    Ophthalmology; 1992 Apr; 99(4):483-6. PubMed ID: 1584563
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sustained ocular delivery of tilisolol to rabbits after topical administration or intravitreal injection of lipophilic prodrug incorporated in liposomes.
    Kawakami S; Yamamura K; Mukai T; Nishida K; Nakamura J; Sakaeda T; Nakashima M; Sasaki H
    J Pharm Pharmacol; 2001 Aug; 53(8):1157-61. PubMed ID: 11518027
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinetics and tolerability of intravitreal pefloxacin in rabbits.
    Cochereau-Massin I; Marrakchi-Benjaafar S; Bauchet J; Vallois JM; Faurisson F; D'Hermies F; Pocidalo JJ
    J Antimicrob Chemother; 1994 Feb; 33(2):231-42. PubMed ID: 8182004
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clearance of intravitreal fluorouracil. Normal and aphakic vitrectomized eyes.
    Jarus G; Blumenkranz M; Hernandez E; Sossi N
    Ophthalmology; 1985 Jan; 92(1):91-6. PubMed ID: 3974999
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Liposome-encapsulated 3H-5FU in rabbits.
    Fishman P; Peyman GA; Hendricks R; Hui SL
    Int Ophthalmol; 1989 Sep; 13(5):361-5. PubMed ID: 2625385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravitreal liposome-encapsulated trifluorothymidine in a rabbit model.
    Liu KR; Peyman GA; Khoobehi B; Alkan H; Fiscella R
    Ophthalmology; 1987 Sep; 94(9):1155-9. PubMed ID: 3120077
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Duration of therapeutic levels of intravitreally injected liposome-encapsulated clindamycin in the rabbit.
    Fiscella R; Peyman GA; Fishman PH
    Can J Ophthalmol; 1987 Oct; 22(6):307-9. PubMed ID: 3427538
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA).
    Cheng L; Hostetler KY; Gardner MF; Avila CP; Bergeron-Lynn G; Severson GM; Freeman WR
    Curr Eye Res; 1999 Mar; 18(3):161-7. PubMed ID: 10342370
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Uptake and clearance of 5-fluorouridine following subconjunctival and intravitreal injection.
    Huang DS; Blumenkranz MS; Hernandez E; Hartzer M
    Retina; 1988; 8(3):205-9. PubMed ID: 3231913
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Liposome-bound cyclosporine: retinal toxicity after intravitreal injection.
    Alghadyan AA; Peyman GA; Khoobehi B; Liu KR
    Int Ophthalmol; 1988; 12(2):105-7. PubMed ID: 3229898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravitreal injection of methotrexate in an experimental rabbit model: determination of pharmacokinetics.
    Ozkan EB; Ozcan AA; Alparslan N
    Indian J Ophthalmol; 2011; 59(3):197-200. PubMed ID: 21586839
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clearance of triamcinolone from vitreous.
    Scholes GN; O'Brien WJ; Abrams GW; Kubicek MF
    Arch Ophthalmol; 1985 Oct; 103(10):1567-9. PubMed ID: 4051860
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Extended Intravitreal Rabbit Eye Residence of Nanoparticles Conjugated With Cationic Arginine Peptides for Intraocular Drug Delivery: In Vivo Imaging.
    Melgar-Asensio I; Kandela I; Aird F; Darjatmoko SR; de Los Rios C; Sorenson CM; Albert DM; Sheibani N; Henkin J
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4071-4081. PubMed ID: 30098194
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ocular dialysis. A new technique for in vivo intraocular pharmacokinetic measurements.
    Ben-Nun J; Cooper RL; Cringle SJ; Constable IJ
    Arch Ophthalmol; 1988 Feb; 106(2):254-9. PubMed ID: 3341984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Water brownness regulates the bioavailability of a fluoroquinolone antibiotic: UV-absorbance as a predictor of ciprofloxacin ecotoxicity.
    Zhang Q; Demeestere K; De Schamphelaere KAC
    Environ Pollut; 2023 Oct; 334():122209. PubMed ID: 37454719
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Liposome-incorporated ciprofloxacin in treatment of murine salmonellosis.
    Magallanes M; Dijkstra J; Fierer J
    Antimicrob Agents Chemother; 1993 Nov; 37(11):2293-7. PubMed ID: 8285608
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A novel quadraport needle with improved intravitreal drug dispersion.
    Asami T; Wong SC; Mitchell PC; Tokunaga CC; Chen YH; Dang L; Giblin FJ; Trese MT
    Retina; 2012 Jun; 32(6):1222-5. PubMed ID: 22596098
    [No Abstract]   [Full Text] [Related]  

  • 59. Intravitreal drug dispersion and needle gauge.
    Montero JA; Merino-Iglesias AA; Pérez-Martín S; Ruiz-Moreno JM
    Acta Ophthalmol; 2013 Dec; 91(8):e646-7. PubMed ID: 23890329
    [No Abstract]   [Full Text] [Related]  

  • 60. Intravitreal injection technique.
    Yorston D
    Community Eye Health; 2014; 27(87):47. PubMed ID: 25918462
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.